MCM
HITK

Matarin Capital Management’s HI-TECH PHARMACAL INC HITK Stock Holding History

Matarin Capital Management’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-21,187
Closed -$703K – 237
2013
Q2 		$703K Buy
+21,187
New +$705K 0.71% 60

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Matarin Capital Management's HITK Position: Q3 2013 in Review

Matarin Capital Management sold out of HI-TECH PHARMACAL INC (HITK) in Q3 2013, closing a stake of 21,187 shares — an estimated $703K sold.

Matarin Capital Management first reported a position in HITK in Q2 2013 and held it in 1 quarter. The position peaked at $703K in Q2 2013. 105 funds tracked by Wall St. Rank hold HITK as of Q3 2013.

  • Matarin Capital Management reported no remaining HI-TECH PHARMACAL INC position as of Q3 2013 after selling out during the quarter.
  • Matarin Capital Management sold 21,187 HI-TECH PHARMACAL INC shares in Q3 2013, an estimated $703K.
  • Matarin Capital Management first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 1 quarter.
  • Matarin Capital Management's HI-TECH PHARMACAL INC position peaked at $703K in Q2 2013.
  • 105 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q3 2013.

Based on Matarin Capital Management's 13F filing for Q3 2013, filed 30 Oct 2013.